Alignment Healthcare (NASDAQ: ALHC) CMO sells 35,951 shares

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of common stock. On June 12, 2026, Kim sold 35,951 shares at a weighted-average price of $19.8589 per share under a pre-arranged Rule 10b5-1 plan adopted on March 13, 2026.

After this transaction, Kim directly holds 331,750 shares of Alignment Healthcare common stock. The filing shows a single net-sell transaction with no derivative exercises or gifts disclosed in this report.

Insider Trade Summary 10b5-1

Net Seller: 35,951 shares ($713,947)

Net Sell 1 txn

Insider Kim Hyong

Role Chief Medical Officer

Sold 35,951 shs ($714K)

Type	Security	Shares	Price	Value
Sale	Common Stock	35,951	$19.8589	$714K

Holdings After Transaction: Common Stock — 331,750 shares (Direct, null)

Footnotes (1)

Date of Rule 10b5-1 plan adoption: 03/13/2026 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.57 to $20.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Key Figures

Shares sold: 35,951 shares Weighted-average sale price: $19.8589 per share Post-transaction holdings: 331,750 shares +3 more

6 metrics

Shares sold 35,951 shares Open-market sale on June 12, 2026

Weighted-average sale price $19.8589 per share Common stock sale on June 12, 2026

Post-transaction holdings 331,750 shares Direct ownership after reported sale

Sale price range $19.57 to $20.24 per share Multiple trades comprising the reported sale

Rule 10b5-1 plan adoption date March 13, 2026 Pre-arranged trading plan governing the sale

Net shares sold in filing 35,951 shares TransactionSummary net-sell direction

Key Terms

Rule 10b5-1 plan, weighted-average price, open-market sale, Form 4

4 terms

Rule 10b5-1 plan regulatory

"Date of Rule 10b5-1 plan adoption: 03/13/2026"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted-average price financial

"The reported price in column 4 is a weighted-average price."

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/15/2026 - 06:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Hyong

(Last)

(First)

(Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE

CALIFORNIA

92868

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/12/2026		S⁽¹⁾		35,951	D	$19.8589⁽²⁾	331,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 03/13/2026

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.57 to $20.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Alignment Healthcare (ALHC) disclose for Hyong Kim?

Alignment Healthcare’s Chief Medical Officer, Hyong Kim, reported selling 35,951 common shares. The sale occurred on June 12, 2026, as an open-market transaction and was executed under a pre-arranged Rule 10b5-1 trading plan adopted earlier in March 2026.

How many Alignment Healthcare (ALHC) shares did Hyong Kim sell and at what price?

Hyong Kim sold 35,951 Alignment Healthcare common shares at a weighted-average price of $19.8589. A footnote explains the shares were sold in multiple trades, with individual prices ranging from $19.57 to $20.24 per share during the transaction.

How many Alignment Healthcare (ALHC) shares does Hyong Kim hold after the sale?

Following the June 12, 2026 sale, Hyong Kim holds 331,750 Alignment Healthcare shares directly. This post-transaction holding figure comes from the reported total shares following the transaction in the Form 4 insider filing.

Was Hyong Kim’s ALHC stock sale made under a Rule 10b5-1 plan?

Yes. The filing states the transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans allow pre-scheduled trades, which can make the timing of insider sales more routine and less discretionary.

What price range did Alignment Healthcare (ALHC) shares trade at in Hyong Kim’s sale?

The filing reports a weighted-average price of $19.8589, with individual trades from $19.57 to $20.24 per share. A footnote notes the company can provide detailed breakdowns of share counts at each price upon request.